These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 11161841)

  • 1. Thyroid carcinoma is characterized by genomic instability: evidence from p53 mutations.
    Shahedian B; Shi Y; Zou M; Farid NR
    Mol Genet Metab; 2001 Feb; 72(2):155-63. PubMed ID: 11161841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. P53 mutations in thyroid carcinoma: tidings from an old foe.
    Farid NR
    J Endocrinol Invest; 2001; 24(7):536-45. PubMed ID: 11508790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of mutations of ras and p53 in benign and malignant thyroid tumors from children exposed to radiation after the Chernobyl nuclear accident.
    Nikiforov YE; Nikiforova MN; Gnepp DR; Fagin JA
    Oncogene; 1996 Aug; 13(4):687-93. PubMed ID: 8761289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylation and repeats in silent and nonsense mutations of p53.
    Kouidou S; Malousi A; Maglaveras N
    Mutat Res; 2006 Jul; 599(1-2):167-77. PubMed ID: 16620878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p53 mutations in lung cancer following radiation therapy for Hodgkin's disease.
    De Benedetti VM; Travis LB; Welsh JA; van Leeuwen FE; Stovall M; Clarke EA; Boice JD; Bennett WP
    Cancer Epidemiol Biomarkers Prev; 1996 Feb; 5(2):93-8. PubMed ID: 8850268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. G:C > A:T mutations and potential epigenetic regulation of p53 in breast cancer.
    Kouidou S; Malousi A; Kyventidis A; Fragou A; Maglaveras N
    Breast Cancer Res Treat; 2007 Dec; 106(3):351-60. PubMed ID: 17505880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic mutations in thyroid carcinoma.
    Taccaliti A; Boscaro M
    Minerva Endocrinol; 2009 Mar; 34(1):11-28. PubMed ID: 19209125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unique association of p53 mutations with undifferentiated but not with differentiated carcinomas of the thyroid gland.
    Ito T; Seyama T; Mizuno T; Tsuyama N; Hayashi T; Hayashi Y; Dohi K; Nakamura N; Akiyama M
    Cancer Res; 1992 Mar; 52(5):1369-71. PubMed ID: 1737400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complete and tissue-independent methylation of CpG sites in the p53 gene: implications for mutations in human cancers.
    Tornaletti S; Pfeifer GP
    Oncogene; 1995 Apr; 10(8):1493-9. PubMed ID: 7731703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of minisatellite and microsatellite instability in radiation-induced post-Chernobyl pediatric thyroid carcinomas.
    Nikiforov YE; Nikiforova M; Fagin JA
    Oncogene; 1998 Oct; 17(15):1983-8. PubMed ID: 9788442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. P53 mutations in colorectal cancer assessed in both genomic DNA and cDNA as compared to the presence of p53 LOH.
    Forslund A; Kressner U; Lönnroth C; Andersson M; Lindmark G; Lundholm K
    Int J Oncol; 2002 Aug; 21(2):409-15. PubMed ID: 12118339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High frequency of frameshift mutation on p53 gene in Taiwanese with non small cell lung cancer.
    Chang MY; Chong IW; Chen FM; Wang JY; Cheng TL; Cheng YJ; Sheu CC; Hung SY; Yang MC; Lin SR
    Cancer Lett; 2005 May; 222(2):195-204. PubMed ID: 15863268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene p53 mutations are restricted to poorly differentiated and undifferentiated carcinomas of the thyroid gland.
    Donghi R; Longoni A; Pilotti S; Michieli P; Della Porta G; Pierotti MA
    J Clin Invest; 1993 Apr; 91(4):1753-60. PubMed ID: 8473515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IARC p53 mutation database: a relational database to compile and analyze p53 mutations in human tumors and cell lines. International Agency for Research on Cancer.
    Hernandez-Boussard T; Rodriguez-Tome P; Montesano R; Hainaut P
    Hum Mutat; 1999; 14(1):1-8. PubMed ID: 10447253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular genetic alterations of FHIT and p53 genes in benign and malignant thyroid gland lesions.
    Pavelić K; Dedivitis RA; Kapitanović S; Cacev T; Guirado CR; Danić D; Radosević S; Brkić K; Pegan B; Krizanac S; Kusić Z; Spaventi S; Bura M
    Mutat Res; 2006 Jul; 599(1-2):45-57. PubMed ID: 16698048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ras mutations are associated with aggressive tumor phenotypes and poor prognosis in thyroid cancer.
    Garcia-Rostan G; Zhao H; Camp RL; Pollan M; Herrero A; Pardo J; Wu R; Carcangiu ML; Costa J; Tallini G
    J Clin Oncol; 2003 Sep; 21(17):3226-35. PubMed ID: 12947056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic pathways of two types of gastric cancer.
    Tahara E
    IARC Sci Publ; 2004; (157):327-49. PubMed ID: 15055305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutations in exons 5-8 of the p53 gene, independent of their type and location, are associated with increased apoptosis and mitosis in invasive breast carcinoma.
    van Slooten HJ; van De Vijver MJ; Borresen AL; Eyfjörd JE; Valgardsdóttir R; Scherneck S; Nesland JM; Devilee P; Cornelisse CJ; van Dierendonck JH
    J Pathol; 1999 Dec; 189(4):504-13. PubMed ID: 10629550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Unique association of p53 mutations with undifferentiated carcinoma of the thyroid].
    Ito T; Seyama T; Hayashi Y; Dohi K; Akiyama M
    Nihon Rinsho; 1994 Apr; 52(4):1069-74. PubMed ID: 8196165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The p53 tumor suppressor gene and nuclear protein: basic science review and relevance in the management of bladder cancer.
    Smith ND; Rubenstein JN; Eggener SE; Kozlowski JM
    J Urol; 2003 Apr; 169(4):1219-28. PubMed ID: 12629332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.